This program will discuss the importance of Physicians being knowledgeable about legal and compliance requirements for participation in the CA CURES program. Providers must also recognize their legal liability and risk if CURES regulations are not followed. Legal and administrative consequences of fraudulent or unauthorized CURES access activities will be discussed. Strategies to reduce risks and maintain compliance with CURES regulations will be presented.
After completing this activity, learners will be able to:
- Identify the regulatory requirements for CURES registration
- Explain the rationale for physician only access to CURES database
- Evaluate the legal responsibility to access CURES prior to ordering controlled substances for a patient
No individual in a position to control or influence the content of this activity has reported relevant financial relationships with commercial interests.
Kathleen Stillwell, RN, MPA/HSA, CPHRM
Senior Patient Safety Risk Manager
The Doctors Company
Richard Cahill, Esq.
Vice President, Associate General Counsel
The Doctors Company
Continuing Education Credit
The Doctors Company is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical educational activities for physicians.
The Doctors Company designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only those credits commensurate with the extent of their participation in the activity.
|Course ID#:||TDS 18023.1|
|Issue Date for This Activity:||12/14/17|
|Expiration Date for This Activity:||01/01/2019|
The information and guidelines contained in this activity are generalized and may not apply to all practice situations. The faculty recommends that legal advice be obtained from a qualified attorney for specific application to your practice. The information is intended for educational purposes and should be used as a reference guide only.
If you have questions, contact firstname.lastname@example.org or call (800) 421-2368, extension 1243.